ישראל - עברית - Ministry of Health

medison pharma ltd - lisdexamfetamine dimesylate - קפסולות - lisdexamfetamine dimesylate 30 mg - lisdexamfetamine

ישראל - עברית - Ministry of Health

medison pharma ltd - lisdexamfetamine dimesylate - קפסולות - lisdexamfetamine dimesylate 50 mg - lisdexamfetamine

ישראל - עברית - Ministry of Health

medison pharma ltd - lisdexamfetamine dimesylate - קפסולות - lisdexamfetamine dimesylate 70 mg - lisdexamfetamine

ישראל - עברית - Ministry of Health

takeda israel ltd - agalsidase alfa - תרכיז להכנת תמיסה לאינפוזיה - agalsidase alfa 1 mg/ml - agalsidase alfa - agalsidase alfa - replagal is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease (alfa-galactosidase a deficiency).

ישראל - עברית - Ministry of Health

takeda israel ltd - velaglucerase alfa - lyophilized powder for infusion - velaglucerase alfa 400 u/vial - velaglucerase alfa - velaglucerase alfa - vpriv is a hydrolytic glucocerebroside – specific enzyme indicated for the long term replacement therapy (ert) for pediatric and adult patients with type 1 gaucher disease.

ישראל - עברית - Ministry of Health

takeda israel ltd - icatibant as acetate - תמיסה להזרקה - icatibant as acetate 30 mg / 3 ml - icatibant - icatibant - symptomatic treatment of acute attacks of hereditary angioedima (hae) in adults (with c1 -esterase-inhibitor deficiency).

ישראל - עברית - Ministry of Health

medison pharma ltd - anagrelide hydrochloride 0.5 mg - capsules - anagrelide - indicated for the treatment of patients with essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.

ישראל - עברית - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 500 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

ישראל - עברית - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 750 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

ישראל - עברית - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 1000 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.